• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿桑葚细胞和桑葚体是检测迟发型法布里病的有用工具。

Urinary mulberry cells and mulberry bodies are useful tool to detect late-onset Fabry disease.

作者信息

Shimohata Homare, Maruyama Hiroshi, Miyamoto Yasunori, Takayasu Mamiko, Hirayama Kouichi, Kobayashi Masaki

机构信息

Department of Nephrology, Tokyo Medical University Ibaraki Medical Center, 3-20-1 Chuo, Ami, Inashiki, 300-0395, Ibaraki, Japan.

出版信息

CEN Case Rep. 2017 Nov;6(2):148-151. doi: 10.1007/s13730-017-0262-5. Epub 2017 Jun 7.

DOI:10.1007/s13730-017-0262-5
PMID:28593486
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5694400/
Abstract

Fabry disease is an X-linked lysosomal storage disorder caused by a lack of α-galactosidase A activity, which leads to the accumulation of globotriaosylceramide in various organs. A complete lack of α-galactosidase A activity in a hemizygous male is the classical phenotype, and some hemizygous males show primarily cardiac and/or renal symptoms that appear in adulthood; this is called the variant type or the late-onset type. The kidney and heart are the major target organs, with damage to these organs related to mortality. Thus, in Fabry patients, early detection and early treatment are critical to longevity. Here, we present a 55-year-old Japanese male patient who was diagnosed with late-onset Fabry nephropathy with cardiomyopathy but with no abnormal urinary findings except for urinary mulberry cells and mulberry bodies. In spite of the absence of abnormal urinary findings, the light microscopic and electron microscopic pathological findings showed extensive deposition of globotriaosylceramide to podocytes. In this paper, we propose that the presence of mulberry cells and mulberry bodies can be used for the earlier detection of Fabry nephropathy, especially the late-onset type.

摘要

法布里病是一种X连锁溶酶体贮积症,由α-半乳糖苷酶A活性缺乏所致,导致球三糖神经酰胺在多个器官蓄积。半合子男性完全缺乏α-半乳糖苷酶A活性是典型表型,部分半合子男性主要表现为成年期出现的心脏和/或肾脏症状;这被称为变异型或迟发型。肾脏和心脏是主要靶器官,这些器官的损害与死亡率相关。因此,在法布里病患者中,早期检测和早期治疗对延长寿命至关重要。在此,我们报告一名55岁的日本男性患者,他被诊断为迟发型法布里肾病合并心肌病,但除了尿桑葚细胞和桑葚体外,尿液检查无异常发现。尽管尿液检查无异常发现,但光镜和电镜病理检查结果显示球三糖神经酰胺广泛沉积于足细胞。在本文中,我们提出桑葚细胞和桑葚体的存在可用于法布里肾病尤其是迟发型的早期检测。

相似文献

1
Urinary mulberry cells and mulberry bodies are useful tool to detect late-onset Fabry disease.尿桑葚细胞和桑葚体是检测迟发型法布里病的有用工具。
CEN Case Rep. 2017 Nov;6(2):148-151. doi: 10.1007/s13730-017-0262-5. Epub 2017 Jun 7.
2
Clinical course and pathological findings of two late-onset Fabry hemizygous patients including mulberry cell counts after enzyme replacement therapy.两名迟发性法布里半合子患者的临床病程及病理结果,包括酶替代治疗后的桑葚细胞计数
CEN Case Rep. 2020 Aug;9(3):237-242. doi: 10.1007/s13730-020-00463-z. Epub 2020 Mar 18.
3
Fabry Nephropathy in a Young Female Patient Presenting with Only Urinary Mulberry Bodies Treated with Chaperone Therapy.仅表现为尿中桑葚体的年轻女性患者的法布里肾病:伴侣疗法治疗
Case Rep Nephrol Dial. 2021 Nov 29;11(3):355-361. doi: 10.1159/000520157. eCollection 2021 Sep-Dec.
4
A Renal Variant of Fabry Disease Diagnosed by the Presence of Urinary Mulberry Cells.通过尿液中桑葚状细胞诊断出的法布里病肾脏变异型。
Intern Med. 2016;55(23):3475-3478. doi: 10.2169/internalmedicine.55.7367. Epub 2016 Dec 1.
5
A Cardiac Variant of Fabry Disease Diagnosed with Chance Urinary Mulberry Cells.通过偶然发现的尿桑葚细胞诊断出的法布里病心脏变异型。
Intern Med. 2018 Dec 1;57(23):3385-3388. doi: 10.2169/internalmedicine.1177-18. Epub 2018 Jul 6.
6
Anderson-Fabry disease: a multiorgan disease.安德森-法布里病:一种多系统疾病。
Curr Pharm Des. 2013;19(33):5974-96. doi: 10.2174/13816128113199990352.
7
Unexpectedly high renal pathological scores of two female siblings with Fabry disease presenting with urinary mulberry cells without microalbuminuria.两名患有法布里病的女性同胞出现尿桑葚状细胞但无微白蛋白尿,其肾脏病理评分意外地高。
Mol Genet Metab Rep. 2022 Apr 22;31:100874. doi: 10.1016/j.ymgmr.2022.100874. eCollection 2022 Jun.
8
Mulberry bodies in the urine sediment of a patient with chronic kidney disease.一名慢性肾病患者尿沉渣中的桑葚体。
Adv Lab Med. 2020 May 5;1(3):20200028. doi: 10.1515/almed-2020-0028. eCollection 2020 Oct.
9
Fabry disease: molecular genetics of the inherited nephropathy.法布里病:遗传性肾病的分子遗传学
Adv Nephrol Necker Hosp. 1989;18:113-27.
10
Fabry's disease discovered with chance urinary mulberry cells: a case report.偶然通过尿液中桑葚状细胞发现法布里病:一例报告
CEN Case Rep. 2013 May;2(1):49-52. doi: 10.1007/s13730-012-0038-x. Epub 2012 Oct 31.

引用本文的文献

1
Urine-derived renal epithelial cells for deep phenotyping and transcriptomic response to therapy in Fabry disease.用于法布里病深度表型分析及治疗转录组反应的尿液来源肾上皮细胞
Clin Sci (Lond). 2025 Jul 28;139(14):791-808. doi: 10.1042/CS20255570.
2
Potential Usefulness of Lifetime Globotriaosylsphingosine Exposure at Diagnosis and Baseline Modified Disease Severity Score in Early-Diagnosed Patients With Fabry Disease.诊断时终生globotriaosylsphingosine暴露及基线修正疾病严重程度评分在早发型法布里病患者中的潜在有用性
Cureus. 2024 May 30;16(5):e61380. doi: 10.7759/cureus.61380. eCollection 2024 May.
3
Mulberry bodies in the urine sediment of a patient with chronic kidney disease.一名慢性肾病患者尿沉渣中的桑葚体。
Adv Lab Med. 2020 May 5;1(3):20200028. doi: 10.1515/almed-2020-0028. eCollection 2020 Oct.
4
Clinical utility of urinary mulberry bodies/cells testing in the diagnosis of Fabry disease.尿桑葚体/细胞检测在法布里病诊断中的临床应用
Mol Genet Metab Rep. 2023 Jun 7;36:100983. doi: 10.1016/j.ymgmr.2023.100983. eCollection 2023 Sep.
5
Early onset of nephrogenic diabetes insipidus due to fabry disease in a child with N215S mutation: Case report and literature review.N215S突变儿童因法布里病导致的早发性肾性尿崩症:病例报告及文献复习
Heliyon. 2023 May 6;9(5):e15993. doi: 10.1016/j.heliyon.2023.e15993. eCollection 2023 May.
6
Fabry Nephropathy in a Young Female Patient Presenting with Only Urinary Mulberry Bodies Treated with Chaperone Therapy.仅表现为尿中桑葚体的年轻女性患者的法布里肾病:伴侣疗法治疗
Case Rep Nephrol Dial. 2021 Nov 29;11(3):355-361. doi: 10.1159/000520157. eCollection 2021 Sep-Dec.
7
Urinary Mulberry Cells as a Biomarker of the Efficacy of Enzyme Replacement Therapy for Fabry Disease.尿桑葚细胞作为法布里病酶替代疗法疗效的生物标志物。
Intern Med. 2020;59(7):971-976. doi: 10.2169/internalmedicine.3813-19. Epub 2020 Apr 1.
8
Clinical course and pathological findings of two late-onset Fabry hemizygous patients including mulberry cell counts after enzyme replacement therapy.两名迟发性法布里半合子患者的临床病程及病理结果,包括酶替代治疗后的桑葚细胞计数
CEN Case Rep. 2020 Aug;9(3):237-242. doi: 10.1007/s13730-020-00463-z. Epub 2020 Mar 18.
9
Effectiveness of immunosuppressive therapy for nephrotic syndrome in a patient with late-onset Fabry disease: a case report and literature review.晚期 Fabry 病患者肾病综合征免疫抑制治疗的疗效:病例报告及文献复习。
BMC Nephrol. 2019 Dec 17;20(1):469. doi: 10.1186/s12882-019-1657-7.
10
Fabry Disease with Pacemaker Implantation as the Initial Event.以植入起搏器为首发事件的法布里病
Intern Med. 2019 Oct 15;58(20):2993-3000. doi: 10.2169/internalmedicine.2468-18. Epub 2019 Jun 27.

本文引用的文献

1
Fabry's disease discovered with chance urinary mulberry cells: a case report.偶然通过尿液中桑葚状细胞发现法布里病:一例报告
CEN Case Rep. 2013 May;2(1):49-52. doi: 10.1007/s13730-012-0038-x. Epub 2012 Oct 31.
2
A Renal Variant of Fabry Disease Diagnosed by the Presence of Urinary Mulberry Cells.通过尿液中桑葚状细胞诊断出的法布里病肾脏变异型。
Intern Med. 2016;55(23):3475-3478. doi: 10.2169/internalmedicine.55.7367. Epub 2016 Dec 1.
3
Fabry Disease Diagnosed Based on the Detection of Urinary Mulberry Bodies.基于尿中桑葚体检测诊断法布里病。
Intern Med. 2016;55(19):2903. doi: 10.2169/internalmedicine.55.7084. Epub 2016 Oct 1.
4
Lipiduria--with special relevance to Fabry disease.脂尿症——与法布里病特别相关。
Clin Chem Lab Med. 2015 Nov;53 Suppl 2:s1465-70. doi: 10.1515/cclm-2015-0499.
5
Copious Podocyturia without Proteinuria and with Normal Renal Function in a Young Adult with Fabry Disease.一名患有法布里病的年轻成年人出现大量足细胞尿但无蛋白尿且肾功能正常
Case Rep Nephrol. 2015;2015:257628. doi: 10.1155/2015/257628. Epub 2015 May 21.
6
Foot process effacement is an early marker of nephropathy in young classic Fabry patients without albuminuria.足突消失是年轻的无蛋白尿经典法布里病患者肾病的早期标志物。
Nephron. 2015;129(1):16-21. doi: 10.1159/000369309. Epub 2014 Dec 17.
7
The kidney in Fabry's disease.法布里病的肾脏。
Clin Genet. 2014 Oct;86(4):301-9. doi: 10.1111/cge.12386. Epub 2014 May 30.
8
Agalsidase benefits renal histology in young patients with Fabry disease.阿加糖酶β治疗法可改善年轻 Fabry 病患者的肾脏组织学。
J Am Soc Nephrol. 2013 Jan;24(1):137-48. doi: 10.1681/ASN.2012030316.
9
Fabry nephropathy: indications for screening and guidance for diagnosis and treatment by the European Renal Best Practice.法布里肾病:欧洲肾脏最佳实践的筛查指征及诊断和治疗指南。
Nephrol Dial Transplant. 2013 Mar;28(3):505-17. doi: 10.1093/ndt/gfs526. Epub 2012 Dec 12.
10
Progressive podocyte injury and globotriaosylceramide (GL-3) accumulation in young patients with Fabry disease.年轻 Fabry 病患者的足细胞渐进性损伤和Globotriaosylceramide(GL-3)蓄积。
Kidney Int. 2011 Mar;79(6):663-670. doi: 10.1038/ki.2010.484. Epub 2010 Dec 15.